Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014)

Updated

Ocular Therapeutix's Depreciation and Depletion was $139,000 in Q3 2014, up 51.1% from $92,000 a year earlier.

Analysis

Ocular Therapeutix (OCUL) Depreciation and Depletion (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 194.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 98.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 139,000.00
Sep 30, 2013 92,000.00
API Access

Ocular Therapeutix Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=OCUL&period=max&api_key=YOUR_API_KEY